Half-century-old TB drugs get a facelift in new cocktails.
Stu
S
Hutson
D000995:Antitubercular Agents / Q000627:therapeutic use*; D001372:Aza Compounds; D002986:Clinical Trials as Topic; D055808:Drug Discovery / Q000639:trends; D004359:Drug Therapy, Combination / Q000379:methods / Q000639:trends*; D024841:Fluoroquinolones; D006801:Humans; D000077266:Moxifloxacin; D009593:Nitroimidazoles; D011718:Pyrazinamide; D011804:Quinolines; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D009593:Nitroimidazoles; D011804:Quinolines; C410767:pretomanid; D011718:Pyrazinamide; D000077266:Moxifloxacin